Onco-genomics

NIPT — Non-Invasive Prenatal Testing

A safe blood test from 10 weeks of pregnancy that screens for chromosomal conditions such as Down syndrome, with high accuracy and a low false positive rate.

NIPT (Non-Invasive Prenatal Testing)

What NIPT screens for

Trisomy 21

Down syndrome

Trisomy 18

Edwards syndrome

Trisomy 13

Patau syndrome

Sex Chromosomes

Optional fetal sex & conditions

10 weeks

Earliest testing window

99%+

Detection accuracy

Low

False positive rate

5–7 days

Typical turnaround

Frequently asked questions

Fetal fraction is the share of fetal DNA present in the mother’s blood sample. By 12 weeks it is usually high enough for a confident NIPT result; a low reading can require a repeat sample.

NIPT has a very low false positive rate compared to older screening methods, though it remains a screening test — a high-risk result should be confirmed with diagnostic testing.

Harmony is one well-known NIPT brand. All NIPT options analyze cell-free fetal DNA in maternal blood to screen for chromosomal conditions.

Yes. NIPT only requires a routine maternal blood draw — there is no risk to the pregnancy, unlike invasive procedures such as amniocentesis.

Screen with confidence

Book your NIPT appointment with our team today.

Scroll to Top